Physician profile
Corinne Casey
NPI 1205193638
$2,459.81
in general payments reported to CMS, 2019-2025
20 companies · $785 in 2025
The $785 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $97.22 · 2021: $143 · 2022: $364 · 2023: $334 · 2024: $417 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,235 · Honoraria: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.23 |
| Honoraria | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $412.60 | 2023-2025 | Total30, Rhopressa |
| Topcon Healthcare, INC. | $300.00 | 2025 | |
| Biotissue Holdings INC. | $224.87 | 2022-2024 | |
| Johnson & Johnson Vision Care, INC. | $219.49 | 2019-2021 | |
| Dompe US, INC. | $212.59 | 2024 | Oxervate |
| Bausch & Lomb Americas INC. | $165.45 | 2022-2024 | Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $158.21 | 2019-2021 | |
| Allergan, INC. | $145.06 | 2019-2020 | |
| Lkc Technologies, INC. | $120.53 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $106.24 | 2025 | |
| Horizon Therapeutics Plc | $102.55 | 2022 | |
| Rxsight INC | $75.00 | 2025 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Oyster Point Pharma, INC. | $68.58 | 2022-2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $26.97 | 2024 | Xdemvy |
| Abbvie INC. | $26.10 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.62 | 2023 | |
| Eyevance Pharmaceuticals LLC | $20.41 | 2022 | |
| Kala Pharmaceuticals, INC. | $19.05 | 2021 | |
| Aerie Pharmaceuticals, INC. | $19.03 | 2020 | |
| Coopervision INC. | $13.46 | 2024 | Onefit Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corinne Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.